CLASS II Drug recall · Reported 11 Mar 2020 · FDA Enforcement Report
Testosterone Cypionate Injection recalled by Fusion IV Pharmaceuticals
Fusion IV Pharmaceuticals is recalling Testosterone Cypionate Injection, Testosterone Cyp IN Grapeseed Oil [] 200 MG/ML, distributed nationwide in the US. The recall was initiated on 15 Jan 2020 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0984-2020
- FDA event ID
- 84978
- Recalling firm
- Fusion IV Pharmaceuticals, Los Angeles, CA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 15 Jan 2020
- FDA classified
- 5 Mar 2020
- Reported
- 11 Mar 2020
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 15 Jan 2020 | Recall initiated by company | |
| 5 Mar 2020 | Classified by FDA | +50 days |
| 11 Mar 2020 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Testosterone Cypionate Injection, TESTOSTERONE CYP IN GRAPESEED OIL [1ML] 200 MG/ML INJECTABLE, For IM Use, 1 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0530-2
Where it was distributed
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility
Which lots are affected?
Lot #: 03062019+51706, Exp 6/28/2020
Where was it sold?
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
62 other products · FDA event 84978This product is part of a recall event; the main page for the event is Polyoxyl Lauryl Ether (Polidocanol) Injection, Laureth recalled.
More recalls from Fusion IV Pharmaceuticals
All 64| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nicotinamide Adenine Dinucleotide (PF) Injection recalled | Fusion IV Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Methylcobalamin Injection, Methylcobalamin 1 MG/ML recalled | Fusion IV Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Triamcinolone Diacetate Injectable Suspension recalled | Fusion IV Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Betamethasone Acetate/Betamethasone recalled | Fusion IV Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Methylprednisolone Acetate Injectable Suspension recalled | Fusion IV Pharmaceuticals | Sterility | Nationwide |
Other Testosterone Cypionate recalls
All 130| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Testosterone Cypionate Injection, 200 mg/mL, CIII recalled | Empower Clinic Services | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200mg per mL recalledTestosterone Cypionate | Eugia US | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200 mg/mL recalledTestosterone Cypionate | Azurity Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Enanthate 100/100mg/ml, a)-vial recalled | TMC Acquisition | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Anastrozole 200mg/1mg/mL, a)-vial recalled | TMC Acquisition | Sterility | Nationwide |